Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung CancerNooshin Hashemi Sadraei, Yan Feng, Lingling Du, et al.Laryngoscope Investigative Otolaryngology|April 18, 2022
A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancerAndrew J Frankart, Nooshin Hashemi Sadraei, Brad Huth, et al.BMC Cancer|March 9, 2023
Spatial characterization and quantification of CD40 expression across cancer typesKatherine M Bates, Ioannis Vathiotis, Tyler MacNeil, et al.Journal of Neuro-Oncology|December 24, 2014
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter studyManmeet S Ahluwalia, Hao Xie, Saurabh Dahiya, et al.Translational Oncology|January 1, 2018
Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case-Control Study of Patients with Head and Neck Squamous Cell CarcinomaTrisha Wise-Draper, Arun Sendilnathan, Sarah Palackdharry, et al.Cancer|October 19, 2019
Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancerShuchi Gulati, Janki Desai, Sarah M Palackdharry, et al.Journal of Neuro-Oncology|August 11, 2018
Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancerNooshin Hashemi-Sadraei, Gaëlle M Müller-Greven, Fadi W Abdul-Karim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2023
Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I StudyLuis Paz-Ares, Stephane Champiat, W Victoria Lai, et al.Cancer Research|November 9, 2022
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate CancerJonathan Chou, Emily A Egusa, Sinan Wang, et al.Pageof 2